Nuvalent’s Alexandra Balcom proposes 22,860-share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Nuvalent, Inc. officer Alexandra Balcom reported a proposed sale of 22,860 Class A common shares, with an approximate sale date of July 1, 2026. The sales are from cashless option exercises that will occur within three months of July 1, 2026.
The securities information lists an aggregate market value of $2,823,896 and 73,562,661 shares outstanding. The shares are identified as acquired from the issuer through NQ stock options for cash on July 1, 2026. December 23, 2025 is listed as the plan adoption or instruction date if relying on Rule 10b5-1.
Key Figures
Key Terms
Cashless Option Exercises financial
NQ Stock Options financial
Rule 10b5-1 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What recent NUVL sales by Alexandra Balcom are listed?
What Rule 10b5-1 date is listed for Alexandra Balcom's proposed NUVL sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.